| scholarly article | Q13442814 |
| P356 | DOI | 10.1097/TP.0000000000000525 |
| P698 | PubMed publication ID | 25606792 |
| P50 | author | Stanley C Jordan | Q96350303 |
| P2093 | author name string | Mark Haas | |
| Alice Peng | |||
| Jua Choi | |||
| James Mirocha | |||
| Aditi Sinha | |||
| Ashley A Vo | |||
| Joseph Kahwaji | |||
| Rafael Villicana | |||
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | desensitization | Q2700499 |
| P304 | page(s) | 1423-1430 | |
| P577 | publication date | 2015-07-01 | |
| P1433 | published in | Transplantation | Q15730500 |
| P1476 | title | Factors Predicting Risk for Antibody-mediated Rejection and Graft Loss in Highly Human Leukocyte Antigen Sensitized Patients Transplanted After Desensitization | |
| P478 | volume | 99 |
| Q36922103 | Antibody-Mediated Rejection in Sensitized Nonhuman Primates: Modeling Human Biology. |
| Q39730025 | Complement Inhibition for Prevention and Treatment of Antibody-Mediated Rejection in Renal Allograft Recipients |
| Q38416698 | Delayed Cytotoxic T Lymphocyte-Associated Protein 4-Immunoglobulin Treatment Reverses Ongoing Alloantibody Responses and Rescues Allografts From Acute Rejection |
| Q47563660 | Desensitisation strategies in high-risk children before kidney transplantation. |
| Q30397952 | Desensitization: Overcoming the Immunologic Barriers to Transplantation |
| Q37149941 | Donor-specific antibodies require preactivated immune system to harm renal transplant. |
| Q49852352 | Heterogeneity of memory B cells |
| Q26766471 | Immunological risk assessment: The key to individualized immunosuppression after kidney transplantation |
| Q46185349 | Outcomes of Highly Sensitized Patients Undergoing Simultaneous Liver and Kidney Transplantation: A Single-Center Experience With Desensitization |
| Q37531788 | Patterns of Early Rejection in Renal Retransplantation: A Single-Center Experience. |
| Q52656964 | Rituximab and Monitoring Strategies for Late Antibody-Mediated Rejection After Kidney Transplantation. |
| Q40586736 | Safety and Efficacy of Alemtuzumab Induction in Highly Sensitized Pediatric Renal Transplant Recipients |
| Q38558820 | Sensitization assessment before kidney transplantation |
| Q64065985 | Successful Third Kidney Transplant After Desensitization for Combined Human Leucocyte Antigen (HLA) and ABO Incompatibility: A Case Report and Review of Literature |
| Q89777486 | Successful desensitization with proteasome inhibition and costimulation blockade in sensitized nonhuman primates |
| Q33874032 | The UK National Registry of ABO and HLA Antibody Incompatible Renal Transplantation: Pretransplant Factors Associated With Outcome in 879 Transplants |
| Q42402671 | Tracing Donor-MHC Class II Reactive B cells in Mouse Cardiac Transplantation: Delayed CTLA4-Ig Treatment Prevents Memory Alloreactive B-Cell Generation |
| Q28069336 | Unraveling the Role of Allo-Antibodies and Transplant Injury |
| Q40634986 | Value of Donor-Specific Anti-HLA Antibody Monitoring and Characterization for Risk Stratification of Kidney Allograft Loss |
Search more.